← Back to Clinical Trials
Recruiting NCT06816797

NCT06816797 Testing the Cog-Fun Aging Program for Older Adults With Subjective Cognitive Decline

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06816797
Status Recruiting
Phase
Sponsor Hebrew University of Jerusalem
Condition Subjective Cognitive Decline (SCD)
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2024-11-20
Primary Completion 2025-08

Trial Parameters

Condition Subjective Cognitive Decline (SCD)
Sponsor Hebrew University of Jerusalem
Study Type INTERVENTIONAL
Phase N/A
Enrollment 40
Sex ALL
Min Age 60 Years
Max Age N/A
Start Date 2024-11-20
Completion 2025-08
Interventions
Cog Fun Ageing interventionCog-Fun Aging Crossover

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this clinical trial is to learn if the Cog-Fun Aging program helps older adults with Subjective Cognitive Decline (SCD) manage memory challenges and improve their daily lives. The main questions it aims to answer are: * Does the program help participants better understand their cognitive challenges in daily life? * Do participants report using more effective strategies to manage their memory difficulties? * Does the Cog-Fun Aging program reduce negative emotions and self-perceptions related to SCD? Researchers will compare participants who complete the Cog-Fun Aging program with those who do not to determine the program's effectiveness. Participants will: Take part in a 10-week program with weekly sessions. Learn about SCD and how it affects daily life. Practice and monitor strategies to manage memory difficulties.

Eligibility Criteria

Inclusion Criteria: * experiencing memory changes and feeling concerned about them * a score of 23 or higher on the MoCA (Montreal Cognitive Assessment) * ability to speak and understand Hebrew sufficiently to participate in a Hebrew-speaking group Exclusion Criteria: * a self-reported health condition that significantly impacts functioning (e.g., uncontrolled diabetes, severe heart/lung disease) * residing in a medical institution or nursing home * currently participating in another SCD treatment

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology